Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History PALI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics PALI

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Palisade Bio Inc

PALI
Current price
0.75 USD -0.0026 USD (-0.35%)
Last closed 0.75 USD
ISIN US6963894026
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 751 733 USD
Yield for 12 month -82.85 %
1Y
3Y
5Y
10Y
15Y
PALI
21.11.2021 - 28.11.2021

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California. Address: 7750 El Camino Real, Carlsbad, CA, United States, 92009

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.67 USD

P/E Ratio

Dividend Yield

Financials PALI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures PALI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

+250 000 USD

Current Quarter

Last Quarter

Current Year

Last Year

+250 000 USD

Current Quarter

Last Quarter

EBITDA -13 493 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -80.94 %
PEG Ratio
Return On Equity TTM -170.72 %
Wall Street Target Price 10.67 USD
Revenue TTM
Book Value 1.21 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -6.07 USD
Diluted Eps TTM -6.07 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation PALI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 234.89
Price Sales TTM 14.03
Enterprise Value EBITDA 0.57
Price Book MRQ 0.70

Technical Indicators PALI

For 52 Weeks

0.60 USD 4.89 USD
50 Day MA 0.72 USD
Shares Short Prior Month 1 116 795
200 Day MA 1.54 USD
Short Ratio 1.78
Shares Short 949 045
Short Percent 23.40 %